Vitamin K is a fat-soluble vitamin crucial for activating proteins involved in blood clotting and calcium metabolism. It has two main natural forms: vitamin K1 (phylloquinone) in leafy greens and vitamin K2 (menaquinones) in animal and fermented foods. The most studied K2 subtypes, menaquinone-4 (MK-4) and menaquinone-7 (MK-7), have key differences affecting their efficacy.
The Role of Vitamin K2 in the Body
Vitamin K2 activates vitamin K-dependent proteins (VKDPs) through carboxylation. These proteins include:
- Osteocalcin: Helps integrate calcium into bone, promoting strength.
 - Matrix Gla Protein (MGP): Prevents calcium deposition in soft tissues like arteries.
 
Insufficient K2 can lead to calcium being directed away from bones and into arteries, potentially contributing to osteoporosis and cardiovascular disease.
Vitamin K2: The Tale of Two Menaquinones (MK-4 and MK-7)
MK-4 and MK-7 both activate VKDPs, but their distinct structures, metabolism, and bioavailability result in different effects.
Menaquinone-4 (MK-4)
MK-4 is a short-chain menaquinone in some animal products and is synthesized from K1 in tissues. Key points about MK-4:
- Short Half-Life: Cleared rapidly from the bloodstream, requiring frequent, high doses for consistent levels.
 - High Dosage: Therapeutic doses used for osteoporosis in Japanese studies (45 mg) are significantly higher than typical supplement amounts.
 - Nutritional Bioavailability: At standard supplement doses, MK-4 is not well-absorbed and doesn't significantly raise serum levels.
 
Menaquinone-7 (MK-7)
MK-7 is a long-chain menaquinone from fermented foods like natto. It is better suited for supplementation due to:
- Long Half-Life: Stays in the bloodstream for about 72 hours, distributing to tissues. This allows for once-daily dosing.
 - High Bioavailability: Well-absorbed and accumulates in the body, providing a stable supply for activating VKDPs.
 - Effectiveness at Lower Doses: Effective at lower nutritional doses than MK-4 due to better bioavailability and half-life.
 
MK-4 vs. MK-7 Comparison Table
| Feature | MK-4 (Menaquinone-4) | MK-7 (Menaquinone-7) | 
|---|---|---|
| Primary Source | Animal products (egg yolks, liver, meat); synthesized in tissues from K1 | Fermented foods (especially natto), some cheeses | 
| Half-Life | Short (approx. 2-6 hours) | Long (approx. 72 hours) | 
| Bioavailability | Poor at nutritional doses; cleared rapidly | High; well-absorbed and accumulates over time | 
| Dosage for Effect | High therapeutic doses required (e.g., 45 mg) | Low nutritional doses effective (e.g., 90-180 mcg) | 
| Dosing Frequency | Multiple times per day for consistent effect | Once daily is sufficient | 
| Focus of Research | Historically used in Japan for osteoporosis; synthetic forms available | Widely researched for bone and cardiovascular health | 
| Research Outcome | Studies show benefits for fracture risk, but evidence on BMD is mixed and often relies on high doses. | Several studies show positive effects on bone mineral density and arterial stiffness. | 
The Best Form of K2 for Health Outcomes
For general supplementation, MK-7 is widely considered superior due to its high bioavailability and long half-life. This ensures consistent activation of VKDPs supporting bone and cardiovascular health. While high-dose MK-4 has shown benefits, its rapid clearance and poor bioavailability at nutritional levels make it less reliable for supplementation.
Bone Health
MK-7's prolonged availability allows for more effective and consistent activation of osteocalcin at lower doses. Studies on MK-7 have shown benefits for bone mineral density, particularly in postmenopausal women, though some studies have had mixed results. High-dose MK-4 studies, mainly from Japan, have shown a reduction in fracture risk.
Cardiovascular Health
MK-7 is particularly beneficial for heart health as it effectively activates MGP, preventing arterial calcification. The Rotterdam Heart Study linked high dietary menaquinone intake (including MK-7) to a reduced risk of coronary heart disease and aortic calcification, unlike K1. MK-7's long half-life helps it consistently target calcium buildup in arteries.
How to Supplement with K2
When choosing a supplement, MK-7 is often recommended for its high bioavailability and long half-life, allowing for once-daily dosing. Since it's a fat-soluble vitamin, take K2 with a meal containing fat for optimal absorption. Consult a healthcare provider before supplementing, especially if taking blood thinners like warfarin, as vitamin K can interfere with these medications.
Conclusion: Making the Right Choice
While both MK-4 and MK-7 offer health benefits, MK-7 is generally preferred for supplementation due to its superior bioavailability, long half-life, and effectiveness at lower daily doses. Its sustained presence in the bloodstream ensures consistent activation of proteins essential for bone and heart health. Dietary sources of MK-7 are primarily natto, while MK-4 is found in smaller amounts in animal products. Given the difficulty of obtaining therapeutic levels from food alone, supplementation is often considered. For most consumers and practitioners, MK-7 is the more practical and effective option.
For more in-depth information, the National Institutes of Health offers detailed fact sheets on vitamin K for health professionals.